US backs efforts to provide Covid jabs to N Korea amid reports of new cases

North Korea has so far refused to accept millions of doses of Covid-19 vaccine proposed in the COVAX global distribution programme, as it had claimed to be coronavirus-free

Kim Jong-Un
North Korean leader Kim Jong Un
IANS Washington
2 min read Last Updated : May 13 2022 | 12:23 PM IST

The US strongly supports providing Covid-19 vaccines to North Korea, a State Department spokesperson said and urged Pyongyang to work with the international community to inoculate its citizens against the virus.

The remarks come shortly after North Korea said some 18,000 people with fever were identified on Thursday alone. It also said six people died on the day, with one of them testing positive for the Omicron variant of Covid.

"We note the media reports regarding the outbreak of Covid-19 in the DPRK," the Department spokesperson told Yonhap News Agency in an email, referring to North Korea by its official name, the Democratic People's Republic of Korea.

"We are concerned about how this might affect the North Korean people and continue to support the provision of vaccines to the DPRK," the spokesperson added.

North Korea issued its first-ever report of a Covid-19 case on Wednesday.

The country on Thursday said more than 350,000 people have been identified with a fever in a short span of time since late April.

The State Department spokesperson said Washington "strongly supports and encourages the efforts of US and international aid and health organisations in seeking to prevent and contain the spread of Covid-19 in the DPRK and to provide other forms of humanitarian assistance to vulnerable groups in the country".

The spokesperson urged Pyongyang to work with such organisations to quickly vaccinate its population.

North Korea has so far refused to accept millions of doses of Covid-19 vaccine proposed in the COVAX global distribution programme, as it had claimed to be coronavirus-free, with strict border controls in place over the past two years against the pandemic.

--IANS

ksk/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :United StatesNorth KoreaCoronavirus Vaccine

First Published: May 13 2022 | 12:23 PM IST

Next Story